Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/02/2022 -- Results Q2 2022 -- 0.45 --
08/02/2022 -- Earnings Call Q2 2022 -- -- --
05/04/2022 -- Results Q1 2022 0.36 0.28 26.22%
05/04/2022 -- Earnings Call Q1 2022 -- -- --
02/22/2022 -- Results Q4 2021 0.44 0.49 -9.53%
02/22/2022 09:30 EST Earnings Call Q4 2021 -- -- --
11/02/2021 -- Results Q3 2021 0.54 0.51 5.79%
11/02/2021 10:30 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/02/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/04/2022
Beat/Miss Upgrade
Return Since -0.98%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
URL https://www.freseniusmedicalcare.com
Investor Relations URL https://www.freseniusmedicalcare.com/en/investors/investors-overview/
HQ State/Province N/A
Sector Healthcare
Industry Medical Care Facilities
Equity Style Large Cap/Blend
Next Earnings Release Aug. 02, 2022
Last Earnings Release May. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 13, 2022

Dividends

Dividend Per Share (TTM) 0.8101
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 1.790
Yield to Sector 1.234
Yield to Industry 1.125
Last Dividend Amt. 0.7093
Dividend Frequency Annually
Last Ex-Dividend Date May. 13, 2022
Yield (TTM) 2.37%
Forward Yield 2.37%
Payout Ratio 45.37%
Cash Payout Ratio 24.40%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
13.78%
1.95%
25.88%
-37.60%
15.64%
14.76%
-20.32%
-5.62%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.67%
--
--
--
--
--
140.6%
216.2%
-36.77%
--
--
--
--
-11.70%
-29.50%
-59.26%
-30.98%
--
--
--
--
40.99%
-20.55%
-66.76%
-44.37%
14.84%
-74.72%
-27.78%
139.2%
-11.90%
112.4%
-5.15%
-40.58%
As of May 20, 2022.

Profile

Edit
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
URL https://www.freseniusmedicalcare.com
Investor Relations URL https://www.freseniusmedicalcare.com/en/investors/investors-overview/
HQ State/Province N/A
Sector Healthcare
Industry Medical Care Facilities
Equity Style Large Cap/Blend
Next Earnings Release Aug. 02, 2022
Last Earnings Release May. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 13, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
BIP645 2.358M USD 3.32%
PZVMX 3.858M USD 2.81%
JCVVX 66.53M USD 2.28%
FMIHX 74.33M USD 2.24%
TBHDX 1.707M USD 2.05%
BNS636 16.87M USD 2.04%
EUR.TO 105335.0 USD 1.93%
PID 14.58M USD 1.82%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter FMS Tweets